The global Migraine Drugs Market is expected to reach USD 163.03 Biliion by the end of 2032, with a valuation of USD 57.85 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 12.2%. The study examines the factors driving and limiting the global Migraine Drugs Market's growth as well...